Cancer Treatment Protocols Expert

About the role

The project aims to strengthen the Syrian Ministry of Health’s institutional capacity and governance. The Key Expert – Cancer Treatment Protocols Expert will provide strategic and technical assistance for developing, harmonising and implementing evidence‑based systemic anti‑cancer therapy protocols, with a focus on chemotherapy, medication safety, pharmacovigilance and clinical quality assurance.

Key responsibilities

• Develop, harmonise and revise national or institutional systemic anti‑cancer therapy protocols, especially chemotherapy protocols.
• Facilitate consensus‑building among clinical stakeholders on standardised, evidence‑based treatment pathways.
• Support adaptation of international guidelines (WHO EML, NCCN, ESMO) to resource‑constrained or fragile health systems.
• Strengthen pharmacovigilance and medication‑safety systems for chemotherapy, including adverse‑event reporting and dose‑verification procedures.
• Design and deliver structured clinical training programmes for oncology teams on protocol implementation, treatment sequencing and toxicity management.
• Develop monitoring and evaluation tools to track treatment adherence, clinical outcomes and safety indicators across multiple oncology centres.

Required profile

• Medical degree with board certification or equivalent specialisation in Clinical Oncology, Medical Oncology, Haematology‑Oncology or Clinical Pharmacology.
• Minimum 10 years of clinical or technical experience in medical oncology, including extensive work on protocol development or harmonisation.
• Prior experience supporting ministries of health or national cancer‑control programmes in post‑conflict or early‑recovery contexts is strongly preferred.
• Excellent written and spoken English; working knowledge of Arabic is a strong asset.

Required skills

• Chemotherapy protocol development and harmonisation.
• Pharmacovigilance and medication‑safety systems for oncology.
• Clinical training programme design for physicians, pharmacists and nursing staff.
• Monitoring and evaluation tool creation for protocol adherence and outcomes.
• Familiarity with WHO Essential Medicines List for cancer, NCCN and ESMO guidelines.